Ketamine News and Research

RSS

Podcast: KHN’s ‘What the Health?’ A ‘healthy’ state of the union

Health policy played a surprisingly robust role in President Donald Trump's 2019 State of the Union address.

7 Feb 2019

Study shows no difference between relief offered by topical pain creams and placebos

In an effort to reduce chronic pain, many people look for hope by paying $20 to thousands of dollars for a tube of prescription topical pain cream or gel.

6 Feb 2019

Compounded pain relief creams not effective finds study

A new study has shown that pain relief creams are no better than dummy or placebo creams when it comes to relieving pain.

6 Feb 2019

Complex interplay of two growth factors key to fast-acting antidepressant actions

A study by researchers at Yale University reveals a complex interplay of two different growth factors in the rapid and long-lasting antidepressant effects of ketamine.

31 Jan 2019

Cannabis prescribed medicinally to the first patient in UK

A 32 year old woman – Carly Barton, has been suffering from a long term painful condition called fibromyalgia. This was after a stroke she had suffered from in her twenties. In a new development, she became the first patient United Kingdom to have been prescribed medical cannabis after a change in the laws.

3 Dec 2018

Toxicologists and pharmacologists meet at international conference in Adelaide

Experts will meet to discuss the latest discoveries in drugs and how best to use existing ones as effectively and safely as possible, at an international conference in Adelaide this week (27-30 November).

27 Nov 2018

Ketamine can be considered as alternative to opioids for short-term pain control in ED

Intravenous, low-dose ketamine is as effective as intravenous morphine in the control of acute pain in adults in the emergency department.

15 Oct 2018

Researchers identify effective ketamine dosage levels for patients with treatment-resistant depression

A study led by Massachusetts General Hospital investigators identifies two subanesthetic dosage levels of the anesthetic drug ketamine that appear to provide significant symptom relief to patients with treatment-resistant depression.

11 Oct 2018

Ketamine’s role in treatment of depression: Study

The anaesthetic drug Ketamine has been shown to be beneficial in some cases of depression and suicidal ideation which have typically failed to respond to other standard antidepressant medications. A new study has explored the actual workings of ketamine in depression and found that the drug can act on the same receptors as opioid pain relievers.

30 Aug 2018

Ketamine's acute antidepressant effect requires opioid system activation, finds study

A new study appearing online today from the American Journal of Psychiatry finds that ketamine's acute antidepressant effect requires opioid system activation, the first time that a receptor site has been shown in humans to be necessary for any antidepressant's mechanism of action.

29 Aug 2018

Ketamine may be potential therapeutic option for adolescents with treatment-resistant depression

A new study has shown a significant average decrease in the Children's Depression Rating Scale among adolescents with treatment-resistant depression who were treated with intravenous ketamine.

2 Aug 2018

Patients with chronic pain feel caught in an opioid-prescribing debate

It started with a rolled ankle during a routine Army training exercise. Shannon Hubbard never imagined it was the prologue to one of the most debilitating pain conditions known to exist, called complex regional pain syndrome.

1 Aug 2018

UA researchers to repurpose ketamine to reduce side effects in Parkinson's patients

The best-known treatment for Parkinson's disease isn't perfect. Named levodopa, the drug can treat the stiffness and slowness of movement associated with the debilitating disease.

19 Jul 2018

Low-dose ketamine found to be as effective as opioids for treating acute pain

Opioids are commonly prescribed in the emergency department for the treatment of acute pain, but due to the epidemic of opioid misuse, analgesic alternatives are being explored.

18 Jul 2018

Finnish researchers gain new insights on brain activity during general anesthesia

Finnish researchers have gained new information on brain activity during general anesthesia by recording changes in the electrical activity of the brain.

3 Jul 2018

Psychedelics and their role in treatment of mental health disorders

Psychedelics such as LSD, magic mushrooms, mescaline etc. have garnered renewed interest in the scientific world because of the possible role they could play in mental health problems. Ketamine remains the only hallucinogen at present that is used clinically as an anesthetic agent. The others are all classified under banned drugs.

2 Jul 2018

Ketamine News and Research

Podcast: KHN’s ‘What the Health?’ A ‘healthy’ state of the union

Study shows no difference between relief offered by topical pain creams and placebos

Compounded pain relief creams not effective finds study

Complex interplay of two growth factors key to fast-acting antidepressant actions

Cannabis prescribed medicinally to the first patient in UK

Toxicologists and pharmacologists meet at international conference in Adelaide

Ketamine can be considered as alternative to opioids for short-term pain control in ED

Researchers identify effective ketamine dosage levels for patients with treatment-resistant depression

Ketamine’s role in treatment of depression: Study

Ketamine's acute antidepressant effect requires opioid system activation, finds study

Ketamine may be potential therapeutic option for adolescents with treatment-resistant depression

Patients with chronic pain feel caught in an opioid-prescribing debate

UA researchers to repurpose ketamine to reduce side effects in Parkinson's patients

Low-dose ketamine found to be as effective as opioids for treating acute pain

Finnish researchers gain new insights on brain activity during general anesthesia

Psychedelics and their role in treatment of mental health disorders

Researchers reveal complexity of NMDA receptor drug discovery target

National trial shows how high-tech strategies may change the field of mental health

Australian paramedics find new drug to quickly and safely calm violent patients

Intranasal formulation of ketamine shows promise in rapid treatment of depression, suicidality

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News